Sectors
IPSC
Century Therapeutics, Inc.
1.97
1 x 1.94
1 x 1.95
bid
ask
-
0.01
0.30%
09:38 AM
timesize
| Ytd | 98.39% | |
| 1y | 302.86% |
1.95
day range
2.03
0.43
52 week range
3.04
| Open | 2.00 | Prev Close | 1.98 | Low | 1.95 | High | 2.03 | Mkt Cap | 171.75M |
| Vol | 23.17K | Avg Vol | 1.26M | EPS | -1.06 | P/E | -1.87 | Forward P/E | -0.76 |
| Beta | 1.57 | Short Ratio | 4.82 | Inst. Own | 61.11% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-13 | 50-d Avg | 2.21 | 200-d Avg | 1.81 | 1yr Est | 9.67 |
| Income Statement | |||
| Operating Expenses | 23.68M | ||
| Research and Development Expense | 17.11M | ||
| Selling, General and Administrative Expense | 6.58M | ||
| Operating Income | -23.68M | ||
| Net Income | -21.64M | ||
| Net Income Common Stock | -21.64M | ||
| Net Income Common Stock (USD) | -21.64M | ||
| Consolidated Income | -21.64M | ||
| Earnings per Basic Share | -0.11 | ||
| Earnings per Basic Share (USD) | -0.11 | ||
| Earnings per Diluted Share | -0.11 | ||
| Earning Before Interest & Taxes (EBIT) | -21.64M | ||
| Earning Before Interest & Taxes (USD) | -21.64M | ||
| Weighted Average Shares | 193.47M | ||
| Weighted Average Shares Diluted | 193.47M | ||
| Balance Sheet | |||
| Cash and Equivalents | 53.41M | ||
| Cash and Equivalents (USD) | 53.41M | ||
| Investments | 165.92M | ||
| Investments Current | 83.76M | ||
| Investments Non-Current | 82.17M | ||
| Current Assets | 139.04M | ||
| Property, Plant & Equipment Net | 68.58M | ||
| Total Assets | 326.55M | ||
| Total Debt | 43.94M | ||
| Current Liabilities | 13.57M | ||
| Debt Non-Current | 43.94M | ||
| Total Liabilities | 61.81M | ||
| Accumulated Retained Earnings (Deficit) | -813.56M | ||
| Accumulated Other Comprehensive Income | -585.00K | ||
| Shareholders Equity | 264.74M | ||
| Shareholders Equity (USD) | 264.74M | ||
| Assets Non-Current | 187.51M | ||
| Total Debt (USD) | 43.94M | ||
| Goodwill and Intangible Assets | 34.20M | ||
| Liabilities Non-Current | 48.24M | ||
| Trade and Non-Trade Payables | 3.15M | ||
| Tax Liabilities | 4.30M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 3.42M | ||
| Net Cash Flow from Financing | 126.62M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -11.25M | ||
| Capital Expenditure | -584.00K | ||
| Issuance (Purchase) of Equity Shares | 126.62M | ||
| Net Cash Flow from Investing | -112.61M | ||
| Net Cash Flow - Investment Acquisitions and Disposals | -112.03M | ||
| Net Cash Flow from Operations | -25.26M | ||
| Share Based Compensation | 1.45M | ||